![]()
Dr. Gersch's Knowledge Base | From Chronic Disease to Longevity
Transparenz-Hinweis (EU AI Act): Die Videoinhalte stammen zu 100% von Dr. Gersch oder seinem medizinischen Team. Das Titelbild und die Text-Zusammenfassungen wurden hingegen maschinell durch eine KI (Künstliche Intelligenz) generiert und sind nicht gesondert ärztlich überprüft.
Today, we explore cellular senescence, a fundamental aspect of the aging process and its impact on chronic diseases. Cellular senescence refers to the state where cells lose their ability to divide and function optimally.
This phenomenon is significant because senescent cells can influence the onset and progression of various diseases.
Cells typically undergo apoptosis, a form of programmed cell death, after a limited number of divisions.
However, certain factors, such as DNA damage from radiation, reactive oxygen species, and mechanical stress, can prevent apoptosis, leading cells to become senescent.
Senescent cells aren't all harmful.
Helpful senescent cells play a role in tissue support, aiding in wound repair, and preventing cancer proliferation. Conversely, deleterious senescent cells promote inflammation, tissue injury, and are linked to age-related diseases.
Senescence can accelerate aging and promote a cancer-permissive environment if the balance of these cells tips unfavorably. Fasting is one proven method to reverse such issues, as it can induce apoptosis in senescent cells, reducing their adverse effects.
Detection of senescent cells can be challenging, as there aren't specific biomarkers. Instead, we rely on markers of inflammation and metabolic health. Research indicates that reducing senescent cell burden improves health and delays aging, evidenced by animal studies.
Senolytic agents are gaining attention for their potential to target and clear deleterious senescent cells, improving age-related health conditions. Moreover, lifestyle interventions like regular exercise, caloric restriction, and intermittent fasting show promise in mitigating the effects of senescence.
Quercetin, a dietary flavonoid, and exercise have shown efficacy in reducing markers of senescence and inflammation. Dasatinib, used in cancer treatment, offers potential in controlled dosing for reducing senescent cells.
However, due to side effects, these treatments require further research and cautious application.
Ultimately, managing cellular senescence involves a combination of scientific knowledge, lifestyle adaptation, and careful medication use.
By understanding the dynamics of senescence, we can explore pathways to healthier aging and improved longevity.